Impact

Misaligned incentives - Some aggregators formularies are designed around higher rebates, rather than lowering client spend.
Conflicts of interest - Several aggregators are owned by pharmacy chains, or competing health plans. What’s best for them isn’t necessarily best for you. Especially when it comes to rebate dollars
Lack of transparency
- Guaranteed rebates? easily manipulated by playing with the denominator, messing with the rebated product list.
- Blended rates - same rebate for all drugs in each category. No insight into what’s driving spend or rebates
- Ambiguous reporting - bad partners will only tell you how many claims and how many dollars. Better partners will give you a line-item breakout. That still doesn’t tell you the whole story

Operates alongside existing PBM relationships.
Tailored solutions that integrate seamlessly with your operations.
Transparency above all else - our focus is to shed light on your pharmacy dollars so you can make informed decisions
Educational tools - Commitment to customer satisfaction- we'll show you the games other aggregators play
No conflict of interest - we are independently owned, not tied to any PBM, drugstore chain or manufacturer
Flexibility in reporting and analytics- NDC level reporting, customized solutions

Lower net cost of prescriptions, higher rebate yields, and improved financial outcomes for healthcare organizations.